Clinical Trials Browser

Interventional × Disease × Gemtuzumab × Clear all

NCT00143975 2010-08-12

Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)

Phase 2 Completed

Other hematologic neoplasm

Disease, Leukemia, Myeloid, Acute